Intercomparison and biokinetic model validation of radionuclide

5,47
MB intake assessment

158
stron

4669
ID International Atomic Energy Agency

2002
rok

CONTENTS

1. INTRODUCTION 1

2. OBJECTIVES.^

3. ORGANIZATION. 3

4. PROGRAMME SCHEDULE. 4

5. RESULTS.^

5.1. General 5

5.2. Results on cases. 6

5.2.1. Case 1: Intake of tritium. 6

5.2.2. Case 2: Intake of 45Ca. 7

5.2.3. Case 3: Single intake of s°Co 8

5.2.4. Case 4: Intake of 90Sr and 90Y. 9

5.2.5. Case 5: Repeated intake of 125I. 11

5.2.6. Case 6: Single intake of 192Ir. 12

5.2.7. Case 7: Multiple intakes of ^I239?u 13

5.2.8. Case 8: Single intake of 238/239/240Pu and 241Am . 14

5.2.9. Case 9: Single intake of 241Am. 16

6. DISCUSSIONS AND CONCLUSION. 17

6.1. Design of test cases 17

6.2. Participants. 19

6.3. Distributing the test cases and receiving the responses. 19

6.4. Compilation, interpretation and analysis of responses 19

6.5. Harmonisation of results 21

6.6. Conclusion 21

REFERENCES^

ANNEX I: PARTICIPATING INSTITUTES 29

ANNEX II: STRUCTURE OF CASES (GENERAL FORM) 30

ANNEX III: GUIDELINES FOR PRESENTING THE RESULTS BY THE PARTICIPANTS. 32

ANNEX IV: STUDY CASES. 33

1. Case 1: Single intake of 3H 33

1.1. The event. 33

1.2. Additional information 33

1.3. Body monitoring data 34

1.4. Excretion monitoring data. 34

1.5. Personal data 36

1.6. Other comments relevant for intake and dose estimation. 36

2. Case 2: Intake of 45Ca 36

2.1. The event.36

2.2. Additional information 37

2.3. Body monitoring data 37

2.4. Excretion monitoring data. 38

2.5. Personal data 38

2.6. Other comments relevant for intake and dose estimation. 39

3. Case 3: Single intake of 60Co. 39

3.1. The event. 39

3.2. Additional information 39

3.3. Body monitoring data 40

3.4. Excretion monitoring data. 41

3.5. Personal data 41

3.6. Other comments relevant for intake and dose estimation. 41

4. Case 4: Intake of 90Sr and 90Y 41

4.1. The event.41

4.2. Additional information 42

4.3. Body monitoring data 43

4.4. Excretion monitoring data. 44

4.5. Personal data44

4.6. Other comments relevant for intake and dose estimation. 45

5. Case 5: Repeated intake of 125I. 45

5.1. The event. 45

5.2. Additional information 45

5.3. Body monitoring data 46

5.4. Excretion monitoring data. 47

5.5. Personal data 47

5.6. Other comments relevant for intake and dose estimation. 47

6. Case 6: Single intake of 192Ir 48

6.1. The event.48

6.2. Additional information 48

6.3. Body monitoring data 49

6.4. Excretion monitoring data. 49

6.5. Personal data 49

6.6. Other comments relevant for intake and dose estimation. 50

7. Case 7: Multiple intakes of 238/239Pu. 50

7.1. Event A50

7.2. Event B 51

7.3. Body monitoring data 52

7.4. Excretion monitoring data. 52

7.5. Personal data 53

7.6. Other comments relevant for intake and dose estimation . 53

8. Case 8: Single intake of 238/239/240Pu and 241Am. 54

8.1. The event.54

8.2. Additional information 54

8.3. Body monitoring data 55

8.4. Excretion monitoring data. 56

8.5. Personal data57

8.6. Other comments relevant for intake and dose estimation. 58

9. Case 9: Single intake of 241Am. 58

9.1. The event. 58

9.2. Additional information 59

9.3. Body monitoring data 59

9.4. Excretion monitoring data. 60

9.5. Faeces activity measurement. 62

9.6. Personal data 64

9.7. Other comments relevant for intake and dose estimation . 64

ANNEX V: RESULTS CASE PER CASE 65

Case 1 — Single intake of 3H 66

Case 2—Intake of 45Ca.69

Case 3 — Single intake of 60Co .75

Case 4 —Intake of 90Sr and 90Y80

Case 5 —Repeated intake of 125I-V.A.86

Case5 — Repeated intake of 125I-P.L91

Case 6 — Single intake of 192Sr.96

Case 7 — Multiple intakes of 238'239Pu — Event A100

Case7 —Multiple intakes of 238"239Pu —Event B104

CaseS —Single intake of 238-239'240Pu and 241Am-238Pu.107

Case 8 - Single intake of 238-239-240Pu and 241Am-239Pu.l 12

Case 8 — Single intake of 238-239-240Pu and 241Am-241Am. 117

Case 9 —Single intake of 241Am.122

ANNEX VI: RESULTS PER LABORATORY 127